Terms: = Head and neck cancer AND MECOM, MDS1-EVI1, EVI1, 2122, ENSG00000085276, Q03112, PRDM3 AND Prognosis
7 results:
1.
Grandits AM; Bromberger S; Heller G; Reinoehl BA; Tomasich E; Schossleitner K; Berghoff AS; Fuereder T; Wieser R
Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35162973
[TBL] [Abstract] [Full Text] [Related]
2. Integrated genomic profiling and modelling for risk stratification in patients with advanced oesophagogastric adenocarcinoma.
Hao D; He S; Harada K; Pizzi MP; Lu Y; Guan P; Chen L; Wang R; Zhang S; Sewastjanow-Silva M; Abdelhakeem A; Shanbhag N; Bhutani M; Han G; Lee JH; Zhao S; Weston B; Blum Murphy M; Waters R; Estrella JS; Roy-Chowdhuri S; Gan Q; Lee JS; Peng G; Hanash SM; Calin GA; Song X; Zhang J; Song S; Wang L; Ajani JA
Gut; 2021 Nov; 70(11):2055-2065. PubMed ID: 33334899
[TBL] [Abstract] [Full Text] [Related]
3. evi1 as a Marker for Lymph Node Metastasis in HNSCC.
Idel C; Ribbat-Idel J; Kuppler P; Krupar R; Offermann A; Vogel W; Rades D; Kirfel J; Wollenberg B; Perner S
Int J Mol Sci; 2020 Jan; 21(3):. PubMed ID: 32013033
[TBL] [Abstract] [Full Text] [Related]
4. evi1 promotes epithelial-to-mesenchymal transition, cancer stem cell features and chemo-/radioresistance in nasopharyngeal carcinoma.
Lu Y; Liang Y; Zheng X; Deng X; Huang W; Zhang G
J Exp Clin Cancer Res; 2019 Feb; 38(1):82. PubMed ID: 30770775
[TBL] [Abstract] [Full Text] [Related]
5. Diagnostic marker signature for esophageal cancer from transcriptome analysis.
Warnecke-Eberz U; Metzger R; Hölscher AH; Drebber U; Bollschweiler E
Tumour Biol; 2016 May; 37(5):6349-58. PubMed ID: 26631031
[TBL] [Abstract] [Full Text] [Related]
6. Adjuvant radioactive iodine therapy is associated with improved survival for patients with intermediate-risk papillary thyroid cancer.
Ruel E; Thomas S; Dinan M; Perkins JM; Roman SA; Sosa JA
J Clin Endocrinol Metab; 2015 Apr; 100(4):1529-36. PubMed ID: 25642591
[TBL] [Abstract] [Full Text] [Related]
7. Amplification of MDS1/evi1 and evi1, located in the 3q26.2 amplicon, is associated with favorable patient prognosis in ovarian cancer.
Nanjundan M; Nakayama Y; Cheng KW; Lahad J; Liu J; Lu K; Kuo WL; Smith-McCune K; Fishman D; Gray JW; Mills GB
Cancer Res; 2007 Apr; 67(7):3074-84. PubMed ID: 17409414
[TBL] [Abstract] [Full Text] [Related]
